Lung Involvement in Systemic Sclerosis
Lung involvement in systemic sclerosis is a serious complication of scleroderma that affects the lungs, leading to symptoms such as shortness of breath, cough, and reduced lung function.
Systemic Sclerosis-Related Lung Disease: Belimumab Study
We are investigating the long-term safety and effects of belimumab in adults with lung disease linked to systemic sclerosis. This study aims to see how the treatment impacts lung function and overall tolerability.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Bronchial Diseases
Bronchial diseases refer to conditions affecting the bronchial tubes, which can lead to symptoms like coughing, wheezing, and difficulty breathing.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a woman who is not pregnant or breastfeeding?
- Have you had any major health issues like heart disease, lung disease, or cancer that are not related to SSc?
- Have you discontinued any study treatment before week 52 of Study 218224?
- Are you capable of giving signed consent for the study?
- Do you have an area of skin that is suitable for an injection in your abdomen or thigh?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitair Ziekenhuis Gent
Systemic Sclerosis Unit
Ledeberg, Belgium
Centre hospitalier universitaire de Liege
Respiratory Medicine
Tilff, Belgium
Region Midtjylland
Reumatologisk Afdeling
Gjellerup, Denmark
Sponsor: Glaxosmithkline Research & Development Limited
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.